RISK BASED INSPECTION [SCHEDULE M-POINT (34.16)]
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.16)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.16-768x1087.jpg)
In a risk-based inspection (RBI), Schedule M point 34.16 checks a high-impact documentation risk: whether the Batch Production Record (BPR) is based on the current, approved Master Formula Record (MFR). If an outdated MFR is used, the batch may be…





![RISK BASED INSPECTION [SCHEDULE M-POINT (34.15)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.15-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.14)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.14-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.13)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.13-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.11-34.12)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.11-34.12-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.9-34.10)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.9-34.10-768x1087.jpg)
![RISK BASED INSPECTION [WHO TRS 986-POINT (34.8)]](https://pharmadevils.com/wp-content/uploads/2024/11/WHO-TRS-986-34.8-1-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.7)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.7-768x1086.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.5-34.6)]](https://pharmadevils.com/wp-content/uploads/2024/11/SCHEDULE-M-34.5-34.6-768x1087.jpg)
![RISK BASED INSPECTION [SCHEDULE M-POINT (34.4)]](https://pharmadevils.com/wp-content/uploads/2024/10/SCHEDULE-M-34.4-768x1087.jpg)